Evaluation of the short-term efficacy of NSAIDs on patients with active ankylosing spondylitis in daily practice: a 3-month, longitudinal, observational study, Rheumatol Int, vol.30, pp.331-371, 2010. ,
Criteria of the classification of spondylarthropathies, Rev Rhum Mal Osteoartic, vol.57, pp.85-94, 1990. ,
update of the ASAS-EULAR management recommendations for axial spondyloarthritis, Annals of the Rheumatic Diseases, 2016. ,
Effectiveness of tumor necrosis factor ? blockers in early axial spondyloarthritis: data from the DESIR cohort, Arthritis & Rheumatology, vol.66, pp.1734-1778, 2014. ,
Body mass index influences the response to infliximab in ankylosing spondylitis, Arthritis Res Ther, vol.14, p.115, 2012. ,
DOI : 10.1186/ar3841
URL : https://hal.archives-ouvertes.fr/inserm-00704843
Obesity and reduction of the response rate to anti-tumor necrosis factor ? in rheumatoid arthritis: an approach to a personalized medicine, Arthritis Care Res (Hoboken), vol.65, pp.94-100, 2013. ,
Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis, Clin Exp Rheumatol, vol.35, pp.145-153, 2017. ,
Impaired response to treatment with tumour necrosis factor ? inhibitors in smokers with axial spondyloarthritis, Ann Rheum Dis, vol.75, pp.532-541, 2016. ,
DOI : 10.1136/annrheumdis-2013-205133
Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry, Rheumatology (Oxford), vol.55, pp.659-68, 2016. ,
Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort, Rheumatology (Oxford), vol.57, pp.619-643, 2018. ,
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis, J Rheumatol, vol.36, pp.801-809, 2009. ,
Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry, Ann Rheum Dis, vol.69, pp.2002-2010, 2010. ,
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study, Arthritis Res Ther, vol.13, p.94, 2011. ,
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebocontrolled trial (ABILITY-1), Ann Rheum Dis, vol.72, pp.815-837, 2013. ,
Predictors of Clinical Remission under Antitumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical Trials, J Rheumatol, vol.42, pp.1418-1444, 2015. ,
Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register, Arthritis Care Res (Hoboken), vol.62, pp.1362-1371, 2010. ,
Body weight, gender and response to TNF-? blockers in axial spondyloarthritis, Rheumatology (Oxford), vol.53, pp.875-81, 2014. ,
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab, BMC Musculoskelet Disord, vol.16, p.166, 2015. ,
The Sex Influence on Response to Tumor Necrosis Factor-? Inhibitors and Remission in Axial Spondyloarthritis, J Rheumatol, vol.45, pp.195-201, 2018. ,
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept, J Rheumatol, vol.32, pp.1751-1755, 2005. ,
Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for, Rheumatology Biologics Register. Rheumatology (Oxford), vol.49, pp.563-70, 2010. ,
MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis, Ann Rheum Dis, vol.67, pp.1276-81, 2008. ,
Effectiveness of Adalimumab in Nonradiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort, Medicine (Baltimore), vol.94, p.1170, 2015. ,
Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis Patients, Biomed Res Int, p.876040, 2015. ,
Tumor necrosis factor ? inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort, Arthritis Rheum, vol.65, pp.3096-106, 2013. ,
C-reactive protein predicts tumor necrosis factor-alpha blocker retention rate in axial ankylosing spondylitis, J Rheumatol, vol.34, pp.2078-81, 2007. ,
Clinical history as a screening test for ankylosing spondylitis, JAMA, vol.237, pp.2613-2617, 1977. ,
Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria, Arthritis Rheum, vol.54, pp.569-78, 2006. ,
The DESIR cohort: a 10-year followup of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients, Joint Bone Spine, vol.78, pp.598-603, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00730858
ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis, Ann Rheum Dis, vol.70, pp.249-51, 2011. ,
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores ,
, Ann Rheum Dis, vol.70, pp.47-53, 2011.
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria, Arthritis Rheum, vol.27, pp.361-369, 1984. ,
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group, Ann Rheum Dis, vol.68, pp.1520-1527, 2009. ,
Adherence to recommendations for the use of anti-tumour necrosis factor and its impact over 5 years of follow-up in axial spondyloarthritis, Rheumatology (Oxford), vol.57, pp.880-90, 2018. ,
Performances of the Assessment of SpondyloArthritis International Society axial spondyloarthritis criteria for diagnostic and classification purposes in patients visiting a rheumatologist because of chronic back pain: results from a multicenter, cross-sectional study, Arthritis Care Res (Hoboken), vol.65, pp.1472-81, 2013. ,
, Age, années, moyenne ± déviation standard (DS)
, Homme
, Durée de maladie, années, moyenne ± DS
, HLA-B27 présent, n (%)
,
, SpA axiale selon les critères ASAS, oui, n (%)
, Tabagisme actif, oui, n (%)
,
, Score ASAS NSAID les six derniers mois, moyenne ± DS